Open AccessComputed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma
Author(s) -
Zhaomin Song,
Jiacheng Ye,
Yongzheng Wang,
Yuliang Li,
Wujie Wang
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_629_19
Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , brachytherapy , confidence interval , clinical endpoint , radiology , single center , response evaluation criteria in solid tumors , transcatheter arterial chemoembolization , retrospective cohort study , surgery , nuclear medicine , radiation therapy , randomized controlled trial , chemotherapy , phases of clinical research
This study aimed to retrospectively assess the outcome of interstitial iodine-125 brachytherapy for unresectable hepatocellular carcinoma (HCC).